Global Circulating Tumor Cell Diagnostics Market Professional Survey Report 2018

Publisher Name :
Date: 26-Jul-2018
No. of pages: 123
Inquire Before Buying

This report studies the global Circulating Tumor Cell Diagnostics market status and forecast, categorizes the global Circulating Tumor Cell Diagnostics market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further development of various tumor markers that can be used along with companion diagnostics to diagnose or monitor various forms of cancer are expected to boost usage rates of CTC tests in the coming years.

Circulating tumor cell detection test possesses the ability to detect, quantify, and analyze tumor cells in the blood of cancer patients. It includes enrichment, detection and analysis of the detected circulating tumor cells. Circulating tumor cells tests are applicable in the characterization of tumor cells through biochemical marker analysis. CTC isolation, detection, and molecular characterization systems find investigational application in prostate, breast, colon, head, neck, skin, lung, and pancreatic cancer

Growing incidences oncology diseases and the introduction of novel biotechnological methods that enable the isolation and quantitation of circulating tumor cells. Furthermore, other factors like early disease diagnosis, cost savings on multiple treatments, drug safety, patient compliance, and optimization of therapies are attributive for rising demand for the preventive medicine, thus influencing the demand for CTC tests.

On course of the forecast period it is expected that over 150 companion diagnostic on-label combinations and a range of personalized therapeutic drugs under clinical trials and development pipelines based on companion diagnostics. The level of adoption of companion diagnostics is expected to significantly increase after these obtain complete FDA approval and are commercialized fully.

The global Circulating Tumor Cell Diagnostics market is valued at 4990 million US$ in 2017 and will reach 10100 million US$ by the end of 2025, growing at a CAGR of 9.2% during 2018-2025.

The major manufacturers covered in this report

- Janssen Diagnostics

- Advanced Cell Diagnostics

- Aviva Biosciences

- Biocept Inc

- Biofluidica Inc.

- CellTraffix Inc.

- Clearbridge BioMedics Pte Ltd

- Epic Sciences Inc.

- Fluxion Biosciences Inc.

- ScreenCell

- Silicon Biosystems

- Sysmex Corporation

- Greiner Bio-One GmbH

- AdnaGen AG

- Apocell Inc

- Biocep Ltd

- Canopus Bioscience Ltd

- Creatv Microtech Inc

- Ikonisys Inc

- IV Diagnostics Inc

- Miltenyi Biotech GmbH

- Nanostring Technologies Inc

- Rarecells Diagnostics.

- Vitatex Inc

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

- North America

- Europe

- China

- Japan

- India

- Southeast Asia

- Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- CTC Enrichment

- CTC Detection

- CTC Analysis

By Application, the market can be split into

- Tumorigenesis research

- EMT biomarkers development

- Cancer stem cell research

- Others

The study objectives of this report are:

- To analyze and study the global Circulating Tumor Cell Diagnostics capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);

- Focuses on the key Circulating Tumor Cell Diagnostics manufacturers, to study the capacity, production, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Circulating Tumor Cell Diagnostics are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Circulating Tumor Cell Diagnostics Manufacturers

Circulating Tumor Cell Diagnostics Distributors/Traders/Wholesalers

Circulating Tumor Cell Diagnostics Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Circulating Tumor Cell Diagnostics market, by end-use.

Detailed analysis and profiles of additional market players.

Global Circulating Tumor Cell Diagnostics Market Professional Survey Report 2018

Table of Contents
Global Circulating Tumor Cell Diagnostics Market Professional Survey Report 2018
1 Industry Overview of Circulating Tumor Cell Diagnostics
1.1 Definition and Specifications of Circulating Tumor Cell Diagnostics
1.1.1 Definition of Circulating Tumor Cell Diagnostics
1.1.2 Specifications of Circulating Tumor Cell Diagnostics
1.2 Classification of Circulating Tumor Cell Diagnostics
1.2.1 CTC Enrichment
1.2.2 CTC Detection
1.2.3 CTC Analysis
1.3 Applications of Circulating Tumor Cell Diagnostics
1.3.1 Tumorigenesis research
1.3.2 EMT biomarkers development
1.3.3 Cancer stem cell research
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Circulating Tumor Cell Diagnostics
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Circulating Tumor Cell Diagnostics
2.3 Manufacturing Process Analysis of Circulating Tumor Cell Diagnostics
2.4 Industry Chain Structure of Circulating Tumor Cell Diagnostics
3 Technical Data and Manufacturing Plants Analysis of Circulating Tumor Cell Diagnostics
3.1 Capacity and Commercial Production Date of Global Circulating Tumor Cell Diagnostics Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Circulating Tumor Cell Diagnostics Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Circulating Tumor Cell Diagnostics Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Circulating Tumor Cell Diagnostics Major Manufacturers in 2017
4 Global Circulating Tumor Cell Diagnostics Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Circulating Tumor Cell Diagnostics Capacity and Growth Rate Analysis
4.2.2 2017 Circulating Tumor Cell Diagnostics Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Circulating Tumor Cell Diagnostics Sales and Growth Rate Analysis
4.3.2 2017 Circulating Tumor Cell Diagnostics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Circulating Tumor Cell Diagnostics Sales Price
4.4.2 2017 Circulating Tumor Cell Diagnostics Sales Price Analysis (Company Segment)
5 Circulating Tumor Cell Diagnostics Regional Market Analysis
5.1 North America Circulating Tumor Cell Diagnostics Market Analysis
5.1.1 North America Circulating Tumor Cell Diagnostics Market Overview
5.1.2 North America 2013-2018E Circulating Tumor Cell Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Circulating Tumor Cell Diagnostics Sales Price Analysis
5.1.4 North America 2017 Circulating Tumor Cell Diagnostics Market Share Analysis
5.2 Europe Circulating Tumor Cell Diagnostics Market Analysis
5.2.1 Europe Circulating Tumor Cell Diagnostics Market Overview
5.2.2 Europe 2013-2018E Circulating Tumor Cell Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Circulating Tumor Cell Diagnostics Sales Price Analysis
5.2.4 Europe 2017 Circulating Tumor Cell Diagnostics Market Share Analysis
5.3 China Circulating Tumor Cell Diagnostics Market Analysis
5.3.1 China Circulating Tumor Cell Diagnostics Market Overview
5.3.2 China 2013-2018E Circulating Tumor Cell Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Circulating Tumor Cell Diagnostics Sales Price Analysis
5.3.4 China 2017 Circulating Tumor Cell Diagnostics Market Share Analysis
5.4 Japan Circulating Tumor Cell Diagnostics Market Analysis
5.4.1 Japan Circulating Tumor Cell Diagnostics Market Overview
5.4.2 Japan 2013-2018E Circulating Tumor Cell Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Circulating Tumor Cell Diagnostics Sales Price Analysis
5.4.4 Japan 2017 Circulating Tumor Cell Diagnostics Market Share Analysis
5.5 Southeast Asia Circulating Tumor Cell Diagnostics Market Analysis
5.5.1 Southeast Asia Circulating Tumor Cell Diagnostics Market Overview
5.5.2 Southeast Asia 2013-2018E Circulating Tumor Cell Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Circulating Tumor Cell Diagnostics Sales Price Analysis
5.5.4 Southeast Asia 2017 Circulating Tumor Cell Diagnostics Market Share Analysis
5.6 India Circulating Tumor Cell Diagnostics Market Analysis
5.6.1 India Circulating Tumor Cell Diagnostics Market Overview
5.6.2 India 2013-2018E Circulating Tumor Cell Diagnostics Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Circulating Tumor Cell Diagnostics Sales Price Analysis
5.6.4 India 2017 Circulating Tumor Cell Diagnostics Market Share Analysis
6 Global 2013-2018E Circulating Tumor Cell Diagnostics Segment Market Analysis (by Type)
6.1 Global 2013-2018E Circulating Tumor Cell Diagnostics Sales by Type
6.2 Different Types of Circulating Tumor Cell Diagnostics Product Interview Price Analysis
6.3 Different Types of Circulating Tumor Cell Diagnostics Product Driving Factors Analysis
6.3.1 CTC Enrichment Growth Driving Factor Analysis
6.3.2 CTC Detection Growth Driving Factor Analysis
6.3.3 CTC Analysis Growth Driving Factor Analysis
7 Global 2013-2018E Circulating Tumor Cell Diagnostics Segment Market Analysis (by Application)
7.1 Global 2013-2018E Circulating Tumor Cell Diagnostics Consumption by Application
7.2 Different Application of Circulating Tumor Cell Diagnostics Product Interview Price Analysis
7.3 Different Application of Circulating Tumor Cell Diagnostics Product Driving Factors Analysis
7.3.1 Tumorigenesis research of Circulating Tumor Cell Diagnostics Growth Driving Factor Analysis
7.3.2 EMT biomarkers development of Circulating Tumor Cell Diagnostics Growth Driving Factor Analysis
7.3.3 Cancer stem cell research of Circulating Tumor Cell Diagnostics Growth Driving Factor Analysis
7.3.4 Others of Circulating Tumor Cell Diagnostics Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Circulating Tumor Cell Diagnostics
8.1 Janssen Diagnostics
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Janssen Diagnostics 2017 Circulating Tumor Cell Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Janssen Diagnostics 2017 Circulating Tumor Cell Diagnostics Business Region Distribution Analysis
8.2 Advanced Cell Diagnostics
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Advanced Cell Diagnostics 2017 Circulating Tumor Cell Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Advanced Cell Diagnostics 2017 Circulating Tumor Cell Diagnostics Business Region Distribution Analysis
8.3 Aviva Biosciences
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Aviva Biosciences 2017 Circulating Tumor Cell Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Aviva Biosciences 2017 Circulating Tumor Cell Diagnostics Business Region Distribution Analysis
8.4 Biocept Inc
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Biocept Inc 2017 Circulating Tumor Cell Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Biocept Inc 2017 Circulating Tumor Cell Diagnostics Business Region Distribution Analysis
8.5 Biofluidica Inc.
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Biofluidica Inc. 2017 Circulating Tumor Cell Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Biofluidica Inc. 2017 Circulating Tumor Cell Diagnostics Business Region Distribution Analysis
8.6 CellTraffix Inc.
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 CellTraffix Inc. 2017 Circulating Tumor Cell Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 CellTraffix Inc. 2017 Circulating Tumor Cell Diagnostics Business Region Distribution Analysis
8.7 Clearbridge BioMedics Pte Ltd
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Clearbridge BioMedics Pte Ltd 2017 Circulating Tumor Cell Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Clearbridge BioMedics Pte Ltd 2017 Circulating Tumor Cell Diagnostics Business Region Distribution Analysis
8.8 Epic Sciences Inc.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Epic Sciences Inc. 2017 Circulating Tumor Cell Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Epic Sciences Inc. 2017 Circulating Tumor Cell Diagnostics Business Region Distribution Analysis
8.9 Fluxion Biosciences Inc.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Fluxion Biosciences Inc. 2017 Circulating Tumor Cell Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Fluxion Biosciences Inc. 2017 Circulating Tumor Cell Diagnostics Business Region Distribution Analysis
8.10 ScreenCell
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 ScreenCell 2017 Circulating Tumor Cell Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 ScreenCell 2017 Circulating Tumor Cell Diagnostics Business Region Distribution Analysis
8.11 Silicon Biosystems
8.12 Sysmex Corporation
8.13 Greiner Bio-One GmbH
8.14 AdnaGen AG
8.15 Apocell Inc
8.16 Biocep Ltd
8.17 Canopus Bioscience Ltd
8.18 Creatv Microtech Inc
8.19 Ikonisys Inc
8.20 IV Diagnostics Inc
8.21 Miltenyi Biotech GmbH
8.22 Nanostring Technologies Inc
8.23 Rarecells Diagnostics.
8.24 Vitatex Inc
9 Development Trend of Analysis of Circulating Tumor Cell Diagnostics Market
9.1 Global Circulating Tumor Cell Diagnostics Market Trend Analysis
9.1.1 Global 2018-2025 Circulating Tumor Cell Diagnostics Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Circulating Tumor Cell Diagnostics Sales Price Forecast
9.2 Circulating Tumor Cell Diagnostics Regional Market Trend
9.2.1 North America 2018-2025 Circulating Tumor Cell Diagnostics Consumption Forecast
9.2.2 Europe 2018-2025 Circulating Tumor Cell Diagnostics Consumption Forecast
9.2.3 China 2018-2025 Circulating Tumor Cell Diagnostics Consumption Forecast
9.2.4 Japan 2018-2025 Circulating Tumor Cell Diagnostics Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Circulating Tumor Cell Diagnostics Consumption Forecast
9.2.6 India 2018-2025 Circulating Tumor Cell Diagnostics Consumption Forecast
9.3 Circulating Tumor Cell Diagnostics Market Trend (Product Type)
9.4 Circulating Tumor Cell Diagnostics Market Trend (Application)
10 Circulating Tumor Cell Diagnostics Marketing Type Analysis
10.1 Circulating Tumor Cell Diagnostics Regional Marketing Type Analysis
10.2 Circulating Tumor Cell Diagnostics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Circulating Tumor Cell Diagnostics by Region
10.4 Circulating Tumor Cell Diagnostics Supply Chain Analysis
11 Consumers Analysis of Circulating Tumor Cell Diagnostics
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Circulating Tumor Cell Diagnostics Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Circulating Tumor Cell Diagnostics
Table Product Specifications of Circulating Tumor Cell Diagnostics
Table Classification of Circulating Tumor Cell Diagnostics
Figure Global Production Market Share of Circulating Tumor Cell Diagnostics by Type in 2017
Figure CTC Enrichment Picture
Table Major Manufacturers of CTC Enrichment
Figure CTC Detection Picture
Table Major Manufacturers of CTC Detection
Figure CTC Analysis Picture
Table Major Manufacturers of CTC Analysis
Table Applications of Circulating Tumor Cell Diagnostics
Figure Global Consumption Volume Market Share of Circulating Tumor Cell Diagnostics by Application in 2017
Figure Tumorigenesis research Examples
Table Major Consumers in Tumorigenesis research
Figure EMT biomarkers development Examples
Table Major Consumers in EMT biomarkers development
Figure Cancer stem cell research Examples
Table Major Consumers in Cancer stem cell research
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Circulating Tumor Cell Diagnostics by Regions
Figure North America Circulating Tumor Cell Diagnostics Market Size (Million USD) (2013-2025)
Figure Europe Circulating Tumor Cell Diagnostics Market Size (Million USD) (2013-2025)
Figure China Circulating Tumor Cell Diagnostics Market Size (Million USD) (2013-2025)
Figure Japan Circulating Tumor Cell Diagnostics Market Size (Million USD) (2013-2025)
Figure Southeast Asia Circulating Tumor Cell Diagnostics Market Size (Million USD) (2013-2025)
Figure India Circulating Tumor Cell Diagnostics Market Size (Million USD) (2013-2025)
Table Circulating Tumor Cell Diagnostics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Circulating Tumor Cell Diagnostics in 2017
Figure Manufacturing Process Analysis of Circulating Tumor Cell Diagnostics
Figure Industry Chain Structure of Circulating Tumor Cell Diagnostics
Table Capacity and Commercial Production Date of Global Circulating Tumor Cell Diagnostics Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Circulating Tumor Cell Diagnostics Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Circulating Tumor Cell Diagnostics Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Circulating Tumor Cell Diagnostics Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Circulating Tumor Cell Diagnostics 2013-2018E
Figure Global 2013-2018E Circulating Tumor Cell Diagnostics Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Circulating Tumor Cell Diagnostics Market Size (Value) and Growth Rate
Table 2013-2018E Global Circulating Tumor Cell Diagnostics Capacity and Growth Rate
Table 2017 Global Circulating Tumor Cell Diagnostics Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Circulating Tumor Cell Diagnostics Sales (K Units) and Growth Rate
Table 2017 Global Circulating Tumor Cell Diagnostics Sales (K Units) List (Company Segment)
Table 2013-2018E Global Circulating Tumor Cell Diagnostics Sales Price (USD/Unit)
Table 2017 Global Circulating Tumor Cell Diagnostics Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Circulating Tumor Cell Diagnostics 2013-2018E
Figure North America 2013-2018E Circulating Tumor Cell Diagnostics Sales Price (USD/Unit)
Figure North America 2017 Circulating Tumor Cell Diagnostics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Circulating Tumor Cell Diagnostics 2013-2018E
Figure Europe 2013-2018E Circulating Tumor Cell Diagnostics Sales Price (USD/Unit)
Figure Europe 2017 Circulating Tumor Cell Diagnostics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Circulating Tumor Cell Diagnostics 2013-2018E
Figure China 2013-2018E Circulating Tumor Cell Diagnostics Sales Price (USD/Unit)
Figure China 2017 Circulating Tumor Cell Diagnostics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Circulating Tumor Cell Diagnostics 2013-2018E
Figure Japan 2013-2018E Circulating Tumor Cell Diagnostics Sales Price (USD/Unit)
Figure Japan 2017 Circulating Tumor Cell Diagnostics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Circulating Tumor Cell Diagnostics 2013-2018E
Figure Southeast Asia 2013-2018E Circulating Tumor Cell Diagnostics Sales Price (USD/Unit)
Figure Southeast Asia 2017 Circulating Tumor Cell Diagnostics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Circulating Tumor Cell Diagnostics 2013-2018E
Figure India 2013-2018E Circulating Tumor Cell Diagnostics Sales Price (USD/Unit)
Figure India 2017 Circulating Tumor Cell Diagnostics Sales Market Share
Table Global 2013-2018E Circulating Tumor Cell Diagnostics Sales (K Units) by Type
Table Different Types Circulating Tumor Cell Diagnostics Product Interview Price
Table Global 2013-2018E Circulating Tumor Cell Diagnostics Sales (K Units) by Application
Table Different Application Circulating Tumor Cell Diagnostics Product Interview Price
Table Janssen Diagnostics Information List
Table Product Overview
Table 2017 Janssen Diagnostics Circulating Tumor Cell Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Janssen Diagnostics Circulating Tumor Cell Diagnostics Business Region Distribution
Table Advanced Cell Diagnostics Information List
Table Product Overview
Table 2017 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Business Region Distribution
Table Aviva Biosciences Information List
Table Product Overview
Table 2017 Aviva Biosciences Circulating Tumor Cell Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Aviva Biosciences Circulating Tumor Cell Diagnostics Business Region Distribution
Table Biocept Inc Information List
Table Product Overview
Table 2017 Biocept Inc Circulating Tumor Cell Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Biocept Inc Circulating Tumor Cell Diagnostics Business Region Distribution
Table Biofluidica Inc. Information List
Table Product Overview
Table 2017 Biofluidica Inc. Circulating Tumor Cell Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Biofluidica Inc. Circulating Tumor Cell Diagnostics Business Region Distribution
Table CellTraffix Inc. Information List
Table Product Overview
Table 2017 CellTraffix Inc. Circulating Tumor Cell Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 CellTraffix Inc. Circulating Tumor Cell Diagnostics Business Region Distribution
Table Clearbridge BioMedics Pte Ltd Information List
Table Product Overview
Table 2017 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Business Region Distribution
Table Epic Sciences Inc. Information List
Table Product Overview
Table 2017 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Business Region Distribution
Table Fluxion Biosciences Inc. Information List
Table Product Overview
Table 2017 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Business Region Distribution
Table ScreenCell Information List
Table Product Overview
Table 2017 ScreenCell Circulating Tumor Cell Diagnostics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 ScreenCell Circulating Tumor Cell Diagnostics Business Region Distribution
Table Silicon Biosystems Information List
Table Sysmex Corporation Information List
Table Greiner Bio-One GmbH Information List
Table AdnaGen AG Information List
Table Apocell Inc Information List
Table Biocep Ltd Information List
Table Canopus Bioscience Ltd Information List
Table Creatv Microtech Inc Information List
Table Ikonisys Inc Information List
Table IV Diagnostics Inc Information List
Table Miltenyi Biotech GmbH Information List
Table Nanostring Technologies Inc Information List
Table Rarecells Diagnostics. Information List
Table Vitatex Inc Information List
Figure Global 2018-2025 Circulating Tumor Cell Diagnostics Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Circulating Tumor Cell Diagnostics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Circulating Tumor Cell Diagnostics Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Circulating Tumor Cell Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Circulating Tumor Cell Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Circulating Tumor Cell Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Circulating Tumor Cell Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Circulating Tumor Cell Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Circulating Tumor Cell Diagnostics Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Circulating Tumor Cell Diagnostics by Type 2018-2025
Table Global Consumption Volume (K Units) of Circulating Tumor Cell Diagnostics by Application 2018-2025
Table Traders or Distributors with Contact Information of Circulating Tumor Cell Diagnostics by Region
  • Global Diindolylmethane Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jun-2019        Price: US 3480 Onwards        Pages: 117
    Diindolylmethane is a natural substance generated when the body breaks down indole-3-carbinol, a compound found in cruciferous vegetables such as broccoli and kale. Scope of the Report: The worldwide market for Diindolylmethane is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Diindolylmethane in global m......
  • Global Acute Migraine Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jun-2019        Price: US 3480 Onwards        Pages: 117
    A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Acute medications fall into general classes of medicines including analgesics, ergotamines and triptans. Scope of the Report: The worldwide market for Acute Migraine Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report ......
  • Global Notoginseng Root Extract Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jun-2019        Price: US 3480 Onwards        Pages: 115
    Notoginseng root extract is derived from the root of the notoginseng plant. Notoginseng is an herb primarily grown for blood-circulation related issues. Scope of the Report: The worldwide market for Notoginseng Root Extract is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Notoginseng Root Extract in glob......
  • Global Antidiuretic Hormone (ADH) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jun-2019        Price: US 3480 Onwards        Pages: 122
    ADH is a hormone stored in the posterior pituitary gland in the brain, regulating water levels in the body. ADH interacts with the kidneys to increase total body water increasing blood volume and blood pressure. The release of ADH is controlled by cells called osmoreceptors and baroreceptors. Scope of the Report: The worldwide market for Antidiuretic Hormone (ADH) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from ......
  • Global Algae Supplements Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jun-2019        Price: US 3480 Onwards        Pages: 118
    Scope of the Report: North America has remained a lucrative market for algae supplements, underpinned in part by the burgeoning demand for algae-based products in the region. APAC is likely to emerge as a high-growth market for algae supplements, upheld by evolving consumer lifestyles and changing dietary patterns across emerging economies in the region. The worldwide market for Algae Supplements is expected to grow at a CAGR of roughly xx% over the next five years, ......
  • Global Folinic Acid Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jun-2019        Price: US 3480 Onwards        Pages: 124
    Folinic acid, also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate and pyrimethamine. Scope of the Report: The worldwide market for Folinic Acid is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Folinic Acid in global market, especially in North America, Europe and ......
  • Global Clinical Nutritional Supplements Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 19-Jun-2019        Price: US 3480 Onwards        Pages: 138
    Clinical nutrition products are specially formulated to nourish and improve the quality of life for people of all ages. Scope of the Report: The global Clinical Nutritional Supplements market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia ......
  • Global Oral Clinical Nutritional Supplements Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 19-Jun-2019        Price: US 3480 Onwards        Pages: 116
    Oral clinical nutritional supplements are sterile liquids, semi-solids or powders, which provide macro and micro nutrients. Scope of the Report: The worldwide market for Oral Clinical Nutritional Supplements is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Oral Clinical Nutritional Supplements in global ......
  • Global Azithromycin Drug Market Insights, Forecast to 2025
    Published: 18-Jun-2019        Price: US 3900 Onwards        Pages: 127
    Azithromycin is an antibiotic useful for the treatment of a number of bacterial infections. The global Azithromycin Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Azithromycin Drug market based on company, product type, end user and key regions. This report studies the global market size of Azithromyc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs